Skip to content

Use of Repetitive Transcranial Magnetic Stimulation to Augment Hypnotic Analgesia

Use of Repetitive Transcranial Magnetic Stimulation to Augment Hypnotic Analgesia

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT02969707
Enrollment
101
Registered
2016-11-21
Start date
2017-04-24
Completion date
2019-12-21
Last updated
2024-12-20

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Fibromyalgia

Keywords

repetitive Transcranial Magnetic Stimulation, functional MRI, Fibromyalgia, Hypnosis, Pain Assessment

Brief summary

The investigators plan to use functional neuroimaging (fMRI) to understand the brain systems affected when hypnosis and hypnotic analgesia are augmented with repetitive transcranial magnetic stimulation (rTMS), a form of non-invasive brain stimulation to 100 people with fibromyalgia, a chronic pain condition. The investigators will measure the effect of rTMS-augmentation on the brain networks underlying hypnotizability, as well as the effect of rTMS-augmentation on hypnotic analgesia networks. The investigators hope to demonstrate that a combination of these psychological and neuromodulatory treatments will be more effective than hypnosis alone, thereby enhancing the depth of hypnosis, range of hypnosis and the efficacy of hypnotic analgesia and hopefully creating a new treatment modality for individuals suffering from pain syndromes such as fibromyalgia pain.

Detailed description

Overall Study Design. The investigators propose to develop a combinatory approach where an integrative technique (hypnosis) is augmented with a neurotechnology (repetitive transcranial magnetic stimulation). This application seeks to utilize the previously established brain-based mechanisms of both hypnosis and repetitive transcranial magnetic stimulation as biomarkers to assess the potential synergistic mechanism of this combinatory approach. 100 low-moderately hypnotizable subjects with fibromyalgia will be identified. The subjects' response to rTMS-augmentation of hypnosis will be measured. The volunteers will be randomized to active or sham rTMS. Two scan sessions will be performed for each subject, with the first scan session investigating the effect of rTMS-augmentation on hypnosis and hypnotizability (120 min scan session) and the second scan session focused on the effect of rTMS-augmented hypnotic analgesia (120 min scan session). * During the course of the study and upon consultation with the manufacturer, sham setting intensity was lowered to reduce the risk adverse events (e.g., scalp damage). The study will require that participants participate in an in-person screening visit, a screening MRI scan and 2 MRI scan sessions that include the TMS and hypnosis. Experimental design. Before each MRI scan session, participants will undergo a preparation session, where hypnotizability and either psychological testing or experimental pain training will be conducted. Volunteer subjects will then participate in 2 MRI scan sessions on two separate days, each lasting approximately 120 mins. Hypnosis induction procedures. Hypnosis will be induced while the subject is in the scanner though the use of headphones and a pre-recorded induction script. Hypnotic instructions will be standardized, and will involve a simple induction instruction used in our prior research on the brain signature of the hypnotic state and in clinical care. The ability to enter and maintain the hypnotic state through such an induction mechanism in the fMRI environment has been previously demonstrated.

Interventions

DEVICEMagPro TMS system (MagVenture, Denmark)

The investigators will perform two applications of 40s of continuous theta-burst stimulation (cTBS) form of rTMS at 80% resting motor threshold (previously determined), with a 15 minute intersession interval. The standardized treatment location for the left DLPFC will be determined by Localite Neuronavigation and targeted at the posterior middle frontal gyrus. The baseline structural scan obtained during the scan 1 will be utilized for this localization process. rTMS will be delivered using a MagPro TMS system (MagVenture, Denmark). sham rTMS will be delivered using a MagPro TMS system (MagVenture, Denmark).sham rTMS will be delivered using a MagPro TMS system (MagVenture, Denmark).

BEHAVIORALHypnosis

Hypnotizability will be measured using the Hypnotic Induction Profile before and after administration of real vs. sham rTMS. Hypnotizability will be measured using the Hypnotic Induction Profile before and after administration of real vs. sham rTMS. Hypnosis will be employed to influence Stroop performance (conflict detection) and for pain management. The hypnotic instructions for this will be pre-recorded and played during fMRI.

Sponsors

National Institutes of Health (NIH)
CollaboratorNIH
National Center for Complementary and Integrative Health (NCCIH)
CollaboratorNIH
Stanford University
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
BASIC_SCIENCE
Masking
QUADRUPLE (Subject, Caregiver, Investigator, Outcomes Assessor)

Masking description

Double blind sham vs. real rTMS; data analysts blind to group assignment; subjects debriefed on their guess about sham vs. real - no better than chance

Eligibility

Sex/Gender
ALL
Age
18 Years to 70 Years
Healthy volunteers
No

Inclusion criteria

* Fulfill 2010 Fibromyalgia Diagnostic Criteria * Age 18 - 70 * Right-handed * Agree to and able to have two fMRI scans as well as rTMS sessions * Willingness to suspend use of analgesic drugs or cough suppressants for 24 hours prior to the scans * Willingness to suspend us of antidepressant drugs for 2 weeks prior to the scans (6 weeks for fluoxetine) * Proficiency in English sufficient to complete questionnaires/follow instructions during fMRI assessments * US Citizen or resident able to receive payment legally * Low-Moderate Hypnotizability in the Hypnotic Induction Profile (score of 0-8) * Normal color vision * Women of childbearing potential must agree to use adequate contraception prior to study entry and continue this for the duration of the study

Exclusion criteria

* A medical condition that would contraindicate the use of rTMS * Any condition that would contraindicate MRI (like ferromagnetic metal in the body) * Pregnancy or breast feeding * Any significant neurologic disease, including dementia, multi-infarct dementia, Parkinson's or Huntington's disease, brain tumor, progressive supranuclear palsy, seizure disorder, subdural hematoma, multiple sclerosis, history of significant head trauma * Current antidepressant use (must be washed out for two weeks prior to starting protocol) * Inability to stop taking medication contraindicated with treatment * High Hypnotizability in the Hypnotic Induction Profile (score \>8) * Any significant psychiatric disorder as identified on the Mini Mental State Exam (Dysthymia not an

Design outcomes

Primary

MeasureTime frameDescription
The Change in Functional Connectivity (FC) Between the Left Dorsolateral Prefrontal Cortex (L-DLPFC) and the Dorsal Anterior Cingulate Cortex (dACC)Baseline and at 15-20 min post-TMS (up to 30 min)Functional MRI (fMRI) measures changes in oxygenated blood in the brain; at rest these levels fluctuate over time. These fluctuations can be similar between different brain regions. FC is the similarity in fluctuations of these fMRI signals and suggests how strongly two regions communicate with each other. We measured how inhibitory continuous theta-burst stimulation (cTBS) over L-DLPFC changes FC between L-DLPFC and dACC. This was done by estimating z-transformed correlation coefficients (CC) for each voxel (-1 to 1) between the L-DLPFC and dACC pre and post cTBS intervention. Negative FC was assigned to voxels with a weight \< 0, positive FC to voxels with weight\> 0. Total FC includes positive and negative voxels. The change in FC is regarded as the change in the sum of these weighted voxels from pre to post cTBS for total, positive and negative FC, respectively. Greater sums of voxels correspond to more significant levels of coordinated activity (positive, negative, or total).

Secondary

MeasureTime frameDescription
Change in Hypnotic Induction Profile ScoreBaseline and Immediately post rTMS (up to 30 min)The investigators used the Hypnotic Induction Profile (HIP) to determine the effect of active, inhibitory rTMS (cTBS) over L-DLPFC on enhancing hypnotizability. HIP scores range from 0 to 10 (low to high hypnotizability).
Change in The Hypnosis Intensity ScaleBaseline and immediately post rTMS (up to 2 hrs)The investigators used the Hypnotic Intensity Scale (HIS) to determine the effect of active, inhibitory rTMS (cTBS) over L-DLPFC on enhancing hypnotic intensity. HIS scores range from 0 to 10 (low to high hypnotic intensity).
The Change in Functional Connectivity (FC) Within The Neural Network Underlying Conflict Regulation.Baseline and at 15-20 min post-TMS (up to 30 min)We examined the effect of active, inhibitory cTBS over L-DLPFC on functional connectivity (FC) in key nodes in the neural network underlying the conflict regulation system. FC between each voxel in the L-DLPFC and the entire dACC was established by estimating z-transformed correlation coefficients (CC) for each voxel (-1 to 1) pre and post cTBS intervention. This paradigm was also used for voxels in the Default Mode Network (DMN) (Schaefer, 2018; Yeo, 2011) to the entire right inferior frontal gyrus (rIFG). Negative FC was assigned to voxels with a weight \< 0, positive FC to voxels with weight \> 0. Total FC includes positive and negative voxels. The change in FC is regarded as the change in the sum of these weighted voxels from pre to post cTBS for total, positive and negative FC, respectively. Greater sums of voxels correspond to more significant levels of coordinated activity (positive, negative, or total).
The Change in Stroop PerformanceBaseline and at 15-20 min post-TMS (up to 30 min)Stroop effect is measured by the response time of a participant during the stroop task. Increases in response time indicate increased stroop effect (SE) and vice versa.
Stroop TaskBaseline and at 15-20 min post-TMS (up to 30 min)Active, inhibitory cTBS effect over L-DLPFC on the neural network that underlies the hypnotic Stroop modulation effect was determined by first estimating the average of connectivity weights for all parcel pairs linking Ventral Attentional Network (VAN) to the DMN. Parcels are determined by extracting mean resting state BOLD time-series for each region of the Schaefer 100 parcellation. A correlation matrix between all parcels is created and FC weights for each pair are established by estimating z-transformed correlation coefficients (CC) (-1 to 1). Each parcel pair is then assigned to one of the 7 resting state networks defined by Yeo et al., (2011). Negative FC is defined for parcel pairs with a weight \< 0, positive FC pairs with weight \> 0 and total FC includes all pairs. FC is thus the average value between parcel pairs in the DMN and VAN pre/post TMS. Greater sums of weighted pairs correspond to more significant levels of coordinated activity (positive, negative, or total).
Linear Relationship Between the Change in FC of the VAN to the DMN and the Change in Stroop Performance (Correlation Coefficient) With no Hypnosis Intervention.Baseline and at 15-20 min post-TMS (up to 1 hr)Spearman's correlation was used to determine the linear relationship between the response time taken to answer incongruent Stroop task blocks (a measure of Stroop performance) and the change the resting-state network FC between the VAN and the DMN when no hypnosis intervention was implemented.
Linear Relationship Between the Change in FC of the VAN to the DMN and the Change in Stroop Performance (Correlation Coefficient) With Hypnosis Intervention.Baseline and at 15-20 min post-TMS (up to 1 hr)Spearman's correlation was used to determine the linear relationship between the response time taken to answer incongruent Stroop task blocks (a measure of Stroop performance) and the change the resting-state network FC between the VAN and the DMN when the hypnosis intervention was implemented.
Linear Relationship Between the Change in FC of the VAN to the DMN and the Change in Stroop Interference (Correlation Coefficient) With no Hypnosis Intervention.Baseline and at 15-20 min post-TMS (up to 1 hr)Spearman's correlation was used to determine the linear relationship between the Stroop interference and the change the resting-state network FC between the VAN and the DMN when no hypnosis intervention was implemented. In psychology, the Stroop effect is the delay in reaction time between congruent and incongruent stimuli.
Linear Relationship Between the Change in FC of the VAN to the DMN and the Change in Stroop Interference (Correlation Coefficient) With Hypnosis Intervention.Baseline and at 15-20 min post-TMS (up to 1 hr)Spearman's correlation was used to determine the linear relationship between the Stroop interference and the change the resting-state network FC between the VAN and the DMN when the hypnosis intervention was implemented. In psychology, the Stroop effect is the delay in reaction time between congruent and incongruent stimuli.
The Change in the Neural Network Underlying Hypnotic IntensityBaseline and 2 hoursBlood oxygen level dependent (BOLD) signal and interleaved TMS-BOLD analyses will be used to determine the effect of active, inhibitory rTMS (cTBS) over L-DLPFC on modulating the neural network that underlies hypnotic intensity.
Change in Sense of Agency Rating Scale (SOARS)Baseline and immediately post-rTMS (up to 30 min)The investigators used the Sense of Agency Rating Scale (SOARS) to determine the effect of active, inhibitory rTMS (cTBS) over L-DLPFC on altering the subjective sense of agency during hypnotizability. SOARS scores are calculated for Involuntariness and Effortlessness, each range from 0 to 35 (low to high).
Metabolic Alterations in Fibromyalgia (FMS) Defined by Excitatory / Inhibitory RatioBaseline Scan (up to 15 min)E/I ratio is defined as the logarithm of the concentration of Glx (excitatory neurotransmitter metabolite complex) /GABA+ (inhibitory neurotransmitter metabolite complex) relative to either water or creatine peak signal and it is a unitless measure ranging from -1 to 1. Logarithmic transformations are used to account for non-normal distributions of metabolite concentrations across participants and ratios \> 0 are thought to be excitatory neurotransmitter dominant while ratios \<0 are thought to be inhibition dominant.
Alterations in Pain Perception in FibromyalgiaBaseline visit (up to 30 min)To characterize clinical pain measures, which are defined as thermal pain threshold and thermal pain tolerance. Thermal pain threshold is determined as the temperature of a thermode determined as painful (degrees Celsius) by a participant. Thermal pain tolerance extends this to the point at which discontinuation is necessary (degrees Celsius).
Metabolic Changes in L-DLPFC Pre- and Post-rTMSBaseline Scan and at 15-20 min post-TMS (up to 30 min)To determine the relationship between the metabolic alterations pre and post-rTMS. Metabolic changes as measured by MEGA-PRESS spectroscopy were assessed by quantification of excitatory (Glx) and inhibitory (GABA+) neurotransmitter complexes. The E/I ratio is defined as the logarithm of the concentration of Glx/GABA+relative to either the reference water or creatine signal and it is a unitless measure ranging from -1 to 1. Logarithmic transformations are used to account for non-normal distributions of metabolite concentrations across participants and ratios \> 0 are thought to be excitatory neurotransmitter dominant while ratios \<0 are thought to be inhibition dominant.
Linear Regression of Thermal Pain Threshold to Logarithm of E/I Ratio as it Relates to Water in Fibromyalgia (Coefficient of Determination)Baseline visit (up to 45 min)Linear regression was used to evaluate the scalar relationship between E/I ratio as it relates to water and Thermal Pain Threshold with E/I as the independent variable and Thermal Pain Threshold as the dependent variable.
Linear Regression of Thermal Pain Tolerance to Logarithm of E/I Ratio as it Relates to Water in Fibromyalgia (Coefficient of Determination)Baseline visit (up to 45 min)Linear regression was used to evaluate the scalar relationship between E/I ratio as it relates to water and Thermal Pain Tolerance with E/I as the independent variable and Thermal Pain Tolerance as the dependent variable.
Linear Regression of Thermal Pain Threshold to Logarithm of E/I Ratio as it Relates to Creatine in Fibromyalgia (Coefficient of Determination)Baseline visit (up to 45 min)Linear regression was used to evaluate the scalar relationship between E/I ratio as it relates to creatine and Thermal Pain Threshold with E/I as the independent variable and Thermal Pain Threshold as the dependent variable.
Linear Regression of Thermal Pain Tolerance to Logarithm of E/I Ratio as it Relates to Creatine in Fibromyalgia (Coefficient of Determination)Baseline visit (up to 45 min)Linear regression was used to evaluate the scalar relationship between E/I ratio as it relates to creatine and Thermal Pain Tolerance with E/I as the independent variable and Thermal Pain Tolerance as the dependent variable.
Change in the Numeric Pain Rating ScaleBaseline and immediately post-rTMS (up to 30 minutes)To determine the effect of active, inhibitory rTMS (cTBS) over L-DLPFC on modulating the neural network that underlies hypnotic analgesia (HA). Numeric Pain Rating Scale scores range from 0 to 10 (low to high pain intensity).

Countries

United States

Participant flow

Pre-assignment details

1,058 individuals completed the online interest survey; 157 completed in-person screening, and 101 were randomized to a study arm.

Participants by arm

ArmCount
Active rTMS
The active group received active repetitive Transcranial Magnetic Stimulation Active repetitive Transcranial Magnetic Stimulation: The investigators performed two applications of 40s of continuous theta-burst stimulation (cTBS) form of rTMS at 80% resting motor threshold (previously determined), with a 15 minute intersession interval. The standardized treatment location for the left DLPFC was determined by Localite Neuronavigation and targeted at the posterior middle frontal gyrus. The baseline structural scan obtained during the scan 1 was utilized for this localization process. rTMS was delivered using a MagPro TMS system (MagVenture, Denmark).
49
Sham rTMS
The sham repetitive Transcranial Magnetic Stimulation group had the stimulation blocked. Sham repetitive Transcranial Magnetic Stimulation: This was identical to active rTMS except the stimulation was blocked. Both active and sham repetitive Transcranial Magnetic Stimulation received simulation from a specially designed coil which is capable of delivering either active rTMS or sham rTMS in a manner, which is randomized by the system itself and therefore blinded to the treater. Sham rTMS was delivered using a MagPro TMS system (MagVenture, Denmark).
52
Total101

Withdrawals & dropouts

PeriodReasonFG000FG001
Overall StudyClaustrophobia22
Overall StudyNon-compliance12
Overall StudyPositive toxicology screen02
Overall StudySevere anxiety01
Overall StudyWithdrawal by Subject65

Baseline characteristics

CharacteristicSham rTMSTotalActive rTMS
Age, Categorical
<=18 years
1 Participants1 Participants0 Participants
Age, Categorical
>=65 years
1 Participants3 Participants2 Participants
Age, Categorical
Between 18 and 65 years
50 Participants97 Participants47 Participants
Age, Continuous50 years
STANDARD_DEVIATION 11.6
49.47 years
STANDARD_DEVIATION 12.15
48.9 years
STANDARD_DEVIATION 12.8
Race (NIH/OMB)
American Indian or Alaska Native
1 Participants2 Participants1 Participants
Race (NIH/OMB)
Asian
1 Participants4 Participants3 Participants
Race (NIH/OMB)
Black or African American
0 Participants0 Participants0 Participants
Race (NIH/OMB)
More than one race
1 Participants6 Participants5 Participants
Race (NIH/OMB)
Native Hawaiian or Other Pacific Islander
0 Participants0 Participants0 Participants
Race (NIH/OMB)
Unknown or Not Reported
9 Participants14 Participants5 Participants
Race (NIH/OMB)
White
40 Participants75 Participants35 Participants
Region of Enrollment
United States
52 participants101 participants49 participants
Sex: Female, Male
Female
48 Participants96 Participants48 Participants
Sex: Female, Male
Male
4 Participants5 Participants1 Participants

Adverse events

Event typeEG000
affected / at risk
EG001
affected / at risk
deaths
Total, all-cause mortality
0 / 490 / 52
other
Total, other adverse events
1 / 492 / 52
serious
Total, serious adverse events
0 / 490 / 52

Outcome results

Primary

The Change in Functional Connectivity (FC) Between the Left Dorsolateral Prefrontal Cortex (L-DLPFC) and the Dorsal Anterior Cingulate Cortex (dACC)

Functional MRI (fMRI) measures changes in oxygenated blood in the brain; at rest these levels fluctuate over time. These fluctuations can be similar between different brain regions. FC is the similarity in fluctuations of these fMRI signals and suggests how strongly two regions communicate with each other. We measured how inhibitory continuous theta-burst stimulation (cTBS) over L-DLPFC changes FC between L-DLPFC and dACC. This was done by estimating z-transformed correlation coefficients (CC) for each voxel (-1 to 1) between the L-DLPFC and dACC pre and post cTBS intervention. Negative FC was assigned to voxels with a weight \< 0, positive FC to voxels with weight\> 0. Total FC includes positive and negative voxels. The change in FC is regarded as the change in the sum of these weighted voxels from pre to post cTBS for total, positive and negative FC, respectively. Greater sums of voxels correspond to more significant levels of coordinated activity (positive, negative, or total).

Time frame: Baseline and at 15-20 min post-TMS (up to 30 min)

Population: Participants with resting-state scans for both pre and post-TMS conditions that passed QC and motion-based scan inclusion criteria; outlier data were excluded.

ArmMeasureGroupValue (MEAN)Dispersion
Active rTMSThe Change in Functional Connectivity (FC) Between the Left Dorsolateral Prefrontal Cortex (L-DLPFC) and the Dorsal Anterior Cingulate Cortex (dACC)Change in sum of positive z-transformed CC.61.98 Z-transformed CCStandard Error 21.63
Active rTMSThe Change in Functional Connectivity (FC) Between the Left Dorsolateral Prefrontal Cortex (L-DLPFC) and the Dorsal Anterior Cingulate Cortex (dACC)Change in sum of negative z-transformed CC.-21.41 Z-transformed CCStandard Error 16.8
Active rTMSThe Change in Functional Connectivity (FC) Between the Left Dorsolateral Prefrontal Cortex (L-DLPFC) and the Dorsal Anterior Cingulate Cortex (dACC)Change in sum of all z-transformed CC.40.56 Z-transformed CCStandard Error 32.34
Sham rTMSThe Change in Functional Connectivity (FC) Between the Left Dorsolateral Prefrontal Cortex (L-DLPFC) and the Dorsal Anterior Cingulate Cortex (dACC)Change in sum of positive z-transformed CC.4.16 Z-transformed CCStandard Error 16.43
Sham rTMSThe Change in Functional Connectivity (FC) Between the Left Dorsolateral Prefrontal Cortex (L-DLPFC) and the Dorsal Anterior Cingulate Cortex (dACC)Change in sum of negative z-transformed CC.-13.22 Z-transformed CCStandard Error 16.8
Sham rTMSThe Change in Functional Connectivity (FC) Between the Left Dorsolateral Prefrontal Cortex (L-DLPFC) and the Dorsal Anterior Cingulate Cortex (dACC)Change in sum of all z-transformed CC.-9.06 Z-transformed CCStandard Error 28.25
Comparison: Examining the Change in sum of positive z-transformed CC.p-value: 0.035t-test, 2 sided
Comparison: Examining the change in sum of all z-transformed CC.p-value: 0.7t-test, 2 sided
Comparison: Examining the change in sum of negative z-transformed CC.p-value: 0.11t-test, 2 sided
Comparison: Examining the change in positive functional connectivity between the L-DLPFC and the dACC within the active group from pre to post TMS.p-value: 0.008t-test, 2 sided
Secondary

Alterations in Pain Perception in Fibromyalgia

To characterize clinical pain measures, which are defined as thermal pain threshold and thermal pain tolerance. Thermal pain threshold is determined as the temperature of a thermode determined as painful (degrees Celsius) by a participant. Thermal pain tolerance extends this to the point at which discontinuation is necessary (degrees Celsius).

Time frame: Baseline visit (up to 30 min)

Population: Participants with baseline MegaPress scan data

ArmMeasureGroupValue (MEAN)Dispersion
Active rTMSAlterations in Pain Perception in FibromyalgiaThermal Pain Tolerance (degrees Celsius)47.8 Degrees CelsiusStandard Deviation 2.51
Active rTMSAlterations in Pain Perception in FibromyalgiaThermal Pain Threshold (degrees Celsius)44.6 Degrees CelsiusStandard Deviation 3.55
Secondary

Change in Hypnotic Induction Profile Score

The investigators used the Hypnotic Induction Profile (HIP) to determine the effect of active, inhibitory rTMS (cTBS) over L-DLPFC on enhancing hypnotizability. HIP scores range from 0 to 10 (low to high hypnotizability).

Time frame: Baseline and Immediately post rTMS (up to 30 min)

Population: Participants with available data are included in the analysis

ArmMeasureValue (MEAN)Dispersion
Active rTMSChange in Hypnotic Induction Profile Score.63 score on a scaleStandard Deviation 1.18
Sham rTMSChange in Hypnotic Induction Profile Score.31 score on a scaleStandard Deviation 1.67
Comparison: Non-parametric analysis, comparison of change (post-treatment minus pre-treatment)p-value: 0.046Mann-Whitney U-test 2-tailed
Comparison: Non-parametric analysis, comparison of change (post-treatment minus pre-treatment)
Secondary

Change in Sense of Agency Rating Scale (SOARS)

The investigators used the Sense of Agency Rating Scale (SOARS) to determine the effect of active, inhibitory rTMS (cTBS) over L-DLPFC on altering the subjective sense of agency during hypnotizability. SOARS scores are calculated for Involuntariness and Effortlessness, each range from 0 to 35 (low to high).

Time frame: Baseline and immediately post-rTMS (up to 30 min)

Population: Participants who completed the protocol and completed all items of the SOARS are included in the analysis.

ArmMeasureGroupValue (MEAN)Dispersion
Active rTMSChange in Sense of Agency Rating Scale (SOARS)Involuntariness.3529 score on a scaleStandard Deviation 3.3654
Active rTMSChange in Sense of Agency Rating Scale (SOARS)Effortlessness.8857 score on a scaleStandard Deviation 3.5378
Sham rTMSChange in Sense of Agency Rating Scale (SOARS)Involuntariness1.1034 score on a scaleStandard Deviation 3.8391
Sham rTMSChange in Sense of Agency Rating Scale (SOARS)Effortlessness.2727 score on a scaleStandard Deviation 3.1551
Comparison: Pre- to post-rTMS change in SOARS scores were calculated for both Active and Sham conditions. Two-tailed t-tests were used to evaluate the difference between the two conditions' change scores.p-value: =0.454t-test, 2 sided
Secondary

Change in The Hypnosis Intensity Scale

The investigators used the Hypnotic Intensity Scale (HIS) to determine the effect of active, inhibitory rTMS (cTBS) over L-DLPFC on enhancing hypnotic intensity. HIS scores range from 0 to 10 (low to high hypnotic intensity).

Time frame: Baseline and immediately post rTMS (up to 2 hrs)

Population: Participants who completed the protocol and completed HIS ratings are included in the analysis.

ArmMeasureValue (MEAN)Dispersion
Active rTMSChange in The Hypnosis Intensity Scale.475 score on a scaleStandard Deviation 2.242
Sham rTMSChange in The Hypnosis Intensity Scale-.128 score on a scaleStandard Deviation 1.49
Comparison: Pre- to post-rTMS change in HIS scores were calculated for both Active and Sham conditions. Two-tailed t-tests were used to evaluate the difference between the two conditions' change scores.p-value: =0.412Mann-Whitney U-test 2-tailed
Secondary

Change in the Numeric Pain Rating Scale

To determine the effect of active, inhibitory rTMS (cTBS) over L-DLPFC on modulating the neural network that underlies hypnotic analgesia (HA). Numeric Pain Rating Scale scores range from 0 to 10 (low to high pain intensity).

Time frame: Baseline and immediately post-rTMS (up to 30 minutes)

Population: Participants with available data are included in the analysis

ArmMeasureGroupValue (MEAN)Dispersion
Active rTMSChange in the Numeric Pain Rating ScaleNon-hypnosis condition-0.13 mean change of scores on a scaleStandard Error 0.2
Active rTMSChange in the Numeric Pain Rating ScaleHypnosis condition-0.09 mean change of scores on a scaleStandard Error 0.2
Sham rTMSChange in the Numeric Pain Rating ScaleNon-hypnosis condition0.19 mean change of scores on a scaleStandard Error 0.19
Sham rTMSChange in the Numeric Pain Rating ScaleHypnosis condition-0.05 mean change of scores on a scaleStandard Error 0.19
Comparison: We used standard mixed-effects modeling to estimate the change (slope) in pain in our 2\*2 pre- and post-assessment design. Pain ratings were calculated by averaging pain ratings across 5 assessments under four conditions (TMS with hypnosis, TMS without hypnosis, Sham with hypnosis, Sham without hypnosis). Based on these change estimates, we derived the two main effects (TMS, Hypnosis) and their interaction effect on the change in pain from the pre- to post-treatment assessment.p-value: 0.49Mixed-effects model
Secondary

Linear Regression of Thermal Pain Threshold to Logarithm of E/I Ratio as it Relates to Creatine in Fibromyalgia (Coefficient of Determination)

Linear regression was used to evaluate the scalar relationship between E/I ratio as it relates to creatine and Thermal Pain Threshold with E/I as the independent variable and Thermal Pain Threshold as the dependent variable.

Time frame: Baseline visit (up to 45 min)

Population: Participants with baseline MegaPress scan data

ArmMeasureValue (NUMBER)
Active rTMSLinear Regression of Thermal Pain Threshold to Logarithm of E/I Ratio as it Relates to Creatine in Fibromyalgia (Coefficient of Determination)0.083 Coefficient of determination
Secondary

Linear Regression of Thermal Pain Threshold to Logarithm of E/I Ratio as it Relates to Water in Fibromyalgia (Coefficient of Determination)

Linear regression was used to evaluate the scalar relationship between E/I ratio as it relates to water and Thermal Pain Threshold with E/I as the independent variable and Thermal Pain Threshold as the dependent variable.

Time frame: Baseline visit (up to 45 min)

Population: Participants with baseline MegaPress scan data

ArmMeasureValue (NUMBER)
Active rTMSLinear Regression of Thermal Pain Threshold to Logarithm of E/I Ratio as it Relates to Water in Fibromyalgia (Coefficient of Determination)0.104 Coefficient of determination
Secondary

Linear Regression of Thermal Pain Tolerance to Logarithm of E/I Ratio as it Relates to Creatine in Fibromyalgia (Coefficient of Determination)

Linear regression was used to evaluate the scalar relationship between E/I ratio as it relates to creatine and Thermal Pain Tolerance with E/I as the independent variable and Thermal Pain Tolerance as the dependent variable.

Time frame: Baseline visit (up to 45 min)

Population: Participants with baseline MegaPress scan data

ArmMeasureValue (NUMBER)
Active rTMSLinear Regression of Thermal Pain Tolerance to Logarithm of E/I Ratio as it Relates to Creatine in Fibromyalgia (Coefficient of Determination)0.103 Coefficient of determination
Secondary

Linear Regression of Thermal Pain Tolerance to Logarithm of E/I Ratio as it Relates to Water in Fibromyalgia (Coefficient of Determination)

Linear regression was used to evaluate the scalar relationship between E/I ratio as it relates to water and Thermal Pain Tolerance with E/I as the independent variable and Thermal Pain Tolerance as the dependent variable.

Time frame: Baseline visit (up to 45 min)

Population: Participants with baseline MegaPress scan data

ArmMeasureValue (NUMBER)
Active rTMSLinear Regression of Thermal Pain Tolerance to Logarithm of E/I Ratio as it Relates to Water in Fibromyalgia (Coefficient of Determination)0.104 Coefficient of determination
Secondary

Linear Relationship Between the Change in FC of the VAN to the DMN and the Change in Stroop Interference (Correlation Coefficient) With Hypnosis Intervention.

Spearman's correlation was used to determine the linear relationship between the Stroop interference and the change the resting-state network FC between the VAN and the DMN when the hypnosis intervention was implemented. In psychology, the Stroop effect is the delay in reaction time between congruent and incongruent stimuli.

Time frame: Baseline and at 15-20 min post-TMS (up to 1 hr)

Population: Population consisted of patients with fibromyalgia who underwent either active or sham cTBS either in combination with hypnosis or without it. Participants were excluded from the original sample for 1) poor Stroop task performance, 2) fMRI imaging problems, 3) missing data. Subjects who had pre and post TMS resting-state fMRI scans that passed QC and motion-based inclusion criteria were included.

ArmMeasureValue (NUMBER)
Active rTMSLinear Relationship Between the Change in FC of the VAN to the DMN and the Change in Stroop Interference (Correlation Coefficient) With Hypnosis Intervention.0.07 Correlation Coefficient
Sham rTMSLinear Relationship Between the Change in FC of the VAN to the DMN and the Change in Stroop Interference (Correlation Coefficient) With Hypnosis Intervention.0.28 Correlation Coefficient
Secondary

Linear Relationship Between the Change in FC of the VAN to the DMN and the Change in Stroop Interference (Correlation Coefficient) With no Hypnosis Intervention.

Spearman's correlation was used to determine the linear relationship between the Stroop interference and the change the resting-state network FC between the VAN and the DMN when no hypnosis intervention was implemented. In psychology, the Stroop effect is the delay in reaction time between congruent and incongruent stimuli.

Time frame: Baseline and at 15-20 min post-TMS (up to 1 hr)

Population: Population consisted of patients with fibromyalgia who underwent either active or sham cTBS either in combination with hypnosis or without it. Participants were excluded from the original sample for 1) poor Stroop task performance, 2) fMRI imaging problems, 3) missing data. Subjects who had pre and post TMS resting-state fMRI scans that passed QC and motion-based inclusion criteria were included.

ArmMeasureValue (NUMBER)
Active rTMSLinear Relationship Between the Change in FC of the VAN to the DMN and the Change in Stroop Interference (Correlation Coefficient) With no Hypnosis Intervention.0.24 Correlation Coefficient
Sham rTMSLinear Relationship Between the Change in FC of the VAN to the DMN and the Change in Stroop Interference (Correlation Coefficient) With no Hypnosis Intervention.-0.44 Correlation Coefficient
Secondary

Linear Relationship Between the Change in FC of the VAN to the DMN and the Change in Stroop Performance (Correlation Coefficient) With Hypnosis Intervention.

Spearman's correlation was used to determine the linear relationship between the response time taken to answer incongruent Stroop task blocks (a measure of Stroop performance) and the change the resting-state network FC between the VAN and the DMN when the hypnosis intervention was implemented.

Time frame: Baseline and at 15-20 min post-TMS (up to 1 hr)

Population: Population consisted of patients with fibromyalgia who underwent either active or sham cTBS either in combination with hypnosis or without it. Participants were excluded from the original sample for 1) poor Stroop task performance, 2) fMRI imaging problems, 3) missing data. Subjects who had pre and post TMS resting-state fMRI scans that passed QC and motion-based inclusion criteria were included.

ArmMeasureValue (NUMBER)
Active rTMSLinear Relationship Between the Change in FC of the VAN to the DMN and the Change in Stroop Performance (Correlation Coefficient) With Hypnosis Intervention.0.16 Correlation Coefficient
Sham rTMSLinear Relationship Between the Change in FC of the VAN to the DMN and the Change in Stroop Performance (Correlation Coefficient) With Hypnosis Intervention.0.16 Correlation Coefficient
Secondary

Linear Relationship Between the Change in FC of the VAN to the DMN and the Change in Stroop Performance (Correlation Coefficient) With no Hypnosis Intervention.

Spearman's correlation was used to determine the linear relationship between the response time taken to answer incongruent Stroop task blocks (a measure of Stroop performance) and the change the resting-state network FC between the VAN and the DMN when no hypnosis intervention was implemented.

Time frame: Baseline and at 15-20 min post-TMS (up to 1 hr)

Population: Population consisted of patients with fibromyalgia who underwent either active or sham cTBS either in combination with hypnosis or without it. Participants were excluded from the original sample for 1) poor Stroop task performance, 2) fMRI imaging problems, 3) missing data. Subjects who had pre and post TMS resting-state fMRI scans that passed QC and motion-based inclusion criteria were included.

ArmMeasureValue (NUMBER)
Active rTMSLinear Relationship Between the Change in FC of the VAN to the DMN and the Change in Stroop Performance (Correlation Coefficient) With no Hypnosis Intervention.0.18 Correlation Coefficient
Sham rTMSLinear Relationship Between the Change in FC of the VAN to the DMN and the Change in Stroop Performance (Correlation Coefficient) With no Hypnosis Intervention.-0.58 Correlation Coefficient
Secondary

Metabolic Alterations in Fibromyalgia (FMS) Defined by Excitatory / Inhibitory Ratio

E/I ratio is defined as the logarithm of the concentration of Glx (excitatory neurotransmitter metabolite complex) /GABA+ (inhibitory neurotransmitter metabolite complex) relative to either water or creatine peak signal and it is a unitless measure ranging from -1 to 1. Logarithmic transformations are used to account for non-normal distributions of metabolite concentrations across participants and ratios \> 0 are thought to be excitatory neurotransmitter dominant while ratios \<0 are thought to be inhibition dominant.

Time frame: Baseline Scan (up to 15 min)

Population: Participants with baseline MegaPress scan data

ArmMeasureGroupValue (MEAN)Dispersion
Active rTMSMetabolic Alterations in Fibromyalgia (FMS) Defined by Excitatory / Inhibitory RatioGABA+/Cr0.10 RatioStandard Deviation 0.02
Active rTMSMetabolic Alterations in Fibromyalgia (FMS) Defined by Excitatory / Inhibitory RatioGABA+/Water1.72 RatioStandard Deviation 0.33
Active rTMSMetabolic Alterations in Fibromyalgia (FMS) Defined by Excitatory / Inhibitory RatioGlx/Cr0.09 RatioStandard Deviation 0.01
Active rTMSMetabolic Alterations in Fibromyalgia (FMS) Defined by Excitatory / Inhibitory RatioGlx/Water5.43 RatioStandard Deviation 0.82
Active rTMSMetabolic Alterations in Fibromyalgia (FMS) Defined by Excitatory / Inhibitory RatioLog E/I Cr-0.06 RatioStandard Deviation 0.08
Active rTMSMetabolic Alterations in Fibromyalgia (FMS) Defined by Excitatory / Inhibitory RatioLog E/I Water0.50 RatioStandard Deviation 0.08
Comparison: In people with FMS, the linear relationship between Thermal Pain Tolerance and E/I ratio as it relates to water was assessed.p-value: 0.023Regression, Linear
Comparison: In people with FMS, the linear relationship between Thermal Pain Threshold and E/I ratio as it relates to water was assessed.p-value: 0.043Regression, Linear
Comparison: In people with FMS, the linear relationship between Thermal Pain Tolerance and E/I ratio as it relates to creatine was assessed.p-value: 0.022Regression, Linear
Comparison: In people with FMS, the linear relationship between Thermal Pain Threshold and E/I ratio as it relates to creatine was assessed.p-value: 0.041Regression, Linear
Secondary

Metabolic Changes in L-DLPFC Pre- and Post-rTMS

To determine the relationship between the metabolic alterations pre and post-rTMS. Metabolic changes as measured by MEGA-PRESS spectroscopy were assessed by quantification of excitatory (Glx) and inhibitory (GABA+) neurotransmitter complexes. The E/I ratio is defined as the logarithm of the concentration of Glx/GABA+relative to either the reference water or creatine signal and it is a unitless measure ranging from -1 to 1. Logarithmic transformations are used to account for non-normal distributions of metabolite concentrations across participants and ratios \> 0 are thought to be excitatory neurotransmitter dominant while ratios \<0 are thought to be inhibition dominant.

Time frame: Baseline Scan and at 15-20 min post-TMS (up to 30 min)

Population: Participants with available data

ArmMeasureGroupValue (MEAN)Dispersion
Active rTMSMetabolic Changes in L-DLPFC Pre- and Post-rTMSLog E/I Water Pre-TMS0.487 RatioStandard Deviation 0.075
Active rTMSMetabolic Changes in L-DLPFC Pre- and Post-rTMSLog E/I Water Post-TMS0.494 RatioStandard Deviation 0.073
Active rTMSMetabolic Changes in L-DLPFC Pre- and Post-rTMSLog E/I Creatine Pre-TMS-0.075 RatioStandard Deviation 0.075
Active rTMSMetabolic Changes in L-DLPFC Pre- and Post-rTMSLog E/I Creatine Post-TMS-0.068 RatioStandard Deviation 0.073
Sham rTMSMetabolic Changes in L-DLPFC Pre- and Post-rTMSLog E/I Creatine Post-TMS-0.057 RatioStandard Deviation 0.108
Sham rTMSMetabolic Changes in L-DLPFC Pre- and Post-rTMSLog E/I Water Pre-TMS0.486 RatioStandard Deviation 0.092
Sham rTMSMetabolic Changes in L-DLPFC Pre- and Post-rTMSLog E/I Creatine Pre-TMS-0.076 RatioStandard Deviation 0.092
Sham rTMSMetabolic Changes in L-DLPFC Pre- and Post-rTMSLog E/I Water Post-TMS0.505 RatioStandard Deviation 0.109
Comparison: Standard ANCOVA testing whether the Post-TMS E/I relative to creatine is predicted for each subject by the intervention (Active / Sham) while covarying for the Pre-TMS E/I ratio relative to creatine.p-value: 0.728ANCOVA
Comparison: Standard ANCOVA testing whether the Post-TMS E/I relative to water is predicted for each subject by the intervention (Active / Sham) while covarying for the Pre-TMS E/I ratio relative to water.p-value: 0.72ANCOVA
Secondary

Stroop Task

Active, inhibitory cTBS effect over L-DLPFC on the neural network that underlies the hypnotic Stroop modulation effect was determined by first estimating the average of connectivity weights for all parcel pairs linking Ventral Attentional Network (VAN) to the DMN. Parcels are determined by extracting mean resting state BOLD time-series for each region of the Schaefer 100 parcellation. A correlation matrix between all parcels is created and FC weights for each pair are established by estimating z-transformed correlation coefficients (CC) (-1 to 1). Each parcel pair is then assigned to one of the 7 resting state networks defined by Yeo et al., (2011). Negative FC is defined for parcel pairs with a weight \< 0, positive FC pairs with weight \> 0 and total FC includes all pairs. FC is thus the average value between parcel pairs in the DMN and VAN pre/post TMS. Greater sums of weighted pairs correspond to more significant levels of coordinated activity (positive, negative, or total).

Time frame: Baseline and at 15-20 min post-TMS (up to 30 min)

Population: Subjects who had pre and post TMS resting-state fMRI scans that passed QC and motion-based inclusion criteria

ArmMeasureValue (MEAN)Dispersion
Active rTMSStroop Task-0.026 Z-transformed CCStandard Error 0.0265
Sham rTMSStroop Task0.155 Z-transformed CCStandard Error 0.0297
p-value: 0.037t-test, 2 sided
p-value: 0.063t-test, 2 sided
p-value: 0.31t-test, 2 sided
Secondary

The Change in Functional Connectivity (FC) Within The Neural Network Underlying Conflict Regulation.

We examined the effect of active, inhibitory cTBS over L-DLPFC on functional connectivity (FC) in key nodes in the neural network underlying the conflict regulation system. FC between each voxel in the L-DLPFC and the entire dACC was established by estimating z-transformed correlation coefficients (CC) for each voxel (-1 to 1) pre and post cTBS intervention. This paradigm was also used for voxels in the Default Mode Network (DMN) (Schaefer, 2018; Yeo, 2011) to the entire right inferior frontal gyrus (rIFG). Negative FC was assigned to voxels with a weight \< 0, positive FC to voxels with weight \> 0. Total FC includes positive and negative voxels. The change in FC is regarded as the change in the sum of these weighted voxels from pre to post cTBS for total, positive and negative FC, respectively. Greater sums of voxels correspond to more significant levels of coordinated activity (positive, negative, or total).

Time frame: Baseline and at 15-20 min post-TMS (up to 30 min)

Population: Population consisted of patients with fibromyalgia who underwent either active or sham cTBS either in combination with hypnosis or without it. Participants were excluded from the original sample for 1) fMRI imaging problems, 2) missing data. For the analyses below additional outliers were excluded on a test by test basis.

ArmMeasureGroupValue (MEAN)Dispersion
Active rTMSThe Change in Functional Connectivity (FC) Within The Neural Network Underlying Conflict Regulation.Change in sum of all z-transformed CC in L-DLPFC.0.01 Z-transformed CCStandard Deviation 0.14
Active rTMSThe Change in Functional Connectivity (FC) Within The Neural Network Underlying Conflict Regulation.Change in sum of positive z-transformed CC in L-DLPFC.33.76 Z-transformed CCStandard Deviation 136.5
Active rTMSThe Change in Functional Connectivity (FC) Within The Neural Network Underlying Conflict Regulation.Change in sum of negative z-transformed CC in L-DLPFC.-20.36 Z-transformed CCStandard Deviation 88.88
Active rTMSThe Change in Functional Connectivity (FC) Within The Neural Network Underlying Conflict Regulation.Change in sum of all z-transformed CC in DMN.0.004 Z-transformed CCStandard Deviation 0.05
Active rTMSThe Change in Functional Connectivity (FC) Within The Neural Network Underlying Conflict Regulation.Change in sum of positive z-transformed CC in DMN.-31.20 Z-transformed CCStandard Deviation 137.73
Active rTMSThe Change in Functional Connectivity (FC) Within The Neural Network Underlying Conflict Regulation.Change in sum of negative z-transformed CC in DMN.51.35 Z-transformed CCStandard Deviation 243.68
Sham rTMSThe Change in Functional Connectivity (FC) Within The Neural Network Underlying Conflict Regulation.Change in sum of positive z-transformed CC in DMN.21.12 Z-transformed CCStandard Deviation 153.54
Sham rTMSThe Change in Functional Connectivity (FC) Within The Neural Network Underlying Conflict Regulation.Change in sum of all z-transformed CC in L-DLPFC.-0.003 Z-transformed CCStandard Deviation 0.13
Sham rTMSThe Change in Functional Connectivity (FC) Within The Neural Network Underlying Conflict Regulation.Change in sum of all z-transformed CC in DMN.-0.01 Z-transformed CCStandard Deviation 0.05
Sham rTMSThe Change in Functional Connectivity (FC) Within The Neural Network Underlying Conflict Regulation.Change in sum of positive z-transformed CC in L-DLPFC.6.39 Z-transformed CCStandard Deviation 99.82
Sham rTMSThe Change in Functional Connectivity (FC) Within The Neural Network Underlying Conflict Regulation.Change in sum of negative z-transformed CC in DMN.-67.65 Z-transformed CCStandard Deviation 219.05
Sham rTMSThe Change in Functional Connectivity (FC) Within The Neural Network Underlying Conflict Regulation.Change in sum of negative z-transformed CC in L-DLPFC.-10.11 Z-transformed CCStandard Deviation 96.55
Secondary

The Change in Stroop Performance

Stroop effect is measured by the response time of a participant during the stroop task. Increases in response time indicate increased stroop effect (SE) and vice versa.

Time frame: Baseline and at 15-20 min post-TMS (up to 30 min)

Population: Population consisted of patients with fibromyalgia who underwent either active or sham cTBS either in combination with hypnosis or without it. Participants were excluded from the original sample for 1) poor Stroop task performance, 2) fMRI imaging problems, 3) missing data. For the analyses below additional outliers were excluded on a test by test basis.

ArmMeasureGroupValue (MEAN)Dispersion
Active rTMSThe Change in Stroop PerformanceMean difference in change in Stroop effect (s) without hypnosis (TMS - no TMS) condition.0.01 SecondsStandard Deviation 0.1
Active rTMSThe Change in Stroop PerformanceMean difference in change in Stroop effect (s) with hypnosis (TMS - no TMS) condition.-0.04 SecondsStandard Deviation 0.12
Sham rTMSThe Change in Stroop PerformanceMean difference in change in Stroop effect (s) without hypnosis (TMS - no TMS) condition.-0.02 SecondsStandard Deviation 0.082
Sham rTMSThe Change in Stroop PerformanceMean difference in change in Stroop effect (s) with hypnosis (TMS - no TMS) condition.-0.009 SecondsStandard Deviation 0.1
Secondary

The Change in the Neural Network Underlying Hypnotic Intensity

Blood oxygen level dependent (BOLD) signal and interleaved TMS-BOLD analyses will be used to determine the effect of active, inhibitory rTMS (cTBS) over L-DLPFC on modulating the neural network that underlies hypnotic intensity.

Time frame: Baseline and 2 hours

Population: During the study, data were not collected using interleaved TMS-BOLD, as originally planned.

Source: ClinicalTrials.gov · Data processed: Feb 7, 2026